Mustafa Erman

hacettepe university

H指数:27

被引数:8,777

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of Cabazitaxel Treatment Beyond 10 Cycles with Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer: A Retrospective 8-Month Landmark Analysis

卡巴他赛治疗超过10个周期与转移性去势抵抗性前列腺癌患者生存结局的关联：一项回顾性8个月里程碑分析

Journal of Clinical Medicine

IF2.9

2026-09-100

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma

avelumab维持治疗转移性尿路上皮癌的预后因素

Immunotherapy

IF2.3

2026-09-020

PRE

Caner Kapar; Oğuzcan Özkan; Eda Eylemer Mocan; Sendag Yaslikaya; Ali Murat Tatlı; Goncagül Akdağ; Hacer Demir; Irem Bilgetekin; Kaan Helvacı; Fatih Selcukbiricik; Fatih Köse; Murat Sari; Gökmen Umut Erdem; Zehra Sucuoğlu İşleyen; Cagatay Arslan; Sinemis Celik; Türkkan Evrensel; Bekir Mert Durukan; Seher Nazli Kazaz; Banu Ozturk; Halil Çelik; Miraç Özen; Pınar Erel; Pervin Can Şancı; Yakup Ergün; Hakan Taban; Ömer Faruk Kuzu; Burcu Ulaş Kahya; Ahmet Melih Arslan; Abdullah Sakin; Murat Araz; Kerem Okutur; Fahri Akgül; Cem Mirili; Alper Sevinç; Fatih Atalah; Yakup Düzköprü; Burcu Gülbağcı; Nurten Kandemir; Hakan Kosku; Esra Aydın; Dilek Erdem; Murad Guliyev; Mesut Yılmaz; Yaşar Çulha; Berksoy Şahin; Pınar Gürsoy; Mustafa Erman; Yüksel Ürün; Deniz Tural

Real-world outcomes of second-line therapy in advanced thymic carcinoma: a multicenter Turkish Oncology Group (TOG) study

晚期胸腺癌二线治疗的实际疗效：一项多中心土耳其肿瘤学组（TOG）研究

BMC Cancer

IF3.4

2026-08-270

Fatih Kus; Fatih Atalah; Gokhan Sahin; Caner Kapar; Damla Gunenc; Erkut Demirciler; Alper Topal; Halil Goksel Guzel; Yakup Duzkopru; Mert Erciyestepe; Ilgin Koc Kus; Omer Denizhan Tatar; Firat Sirvan; Gozde Agdas; Bilgesah Kilictas; Irem Ugurlu; Abdussamet Celebi; Goncagul Akdag; Dogan Bayram; Aysegul Merc Cetinkaya; Ilknur Deliktas Onur; Taliha Guclu; Omer Faruk Elcicek; Sendag Yaslikaya; Elif Sahin; Pinar Gursoy; Ozturk Ates; Abdullah Sakin; Harun Muglu; Murad Guliyev; Nigar Rustamova Cennet; Melike Ozcelik; Melek Karakurt Eryilmaz; Ahmet Bilici; Nebi Serkan Demirci; Mehmet Ali Sendur; Saadettin Kilickap; Derya Kivrak Salim; Ozlem Er; Gamze Gokoz Dogu; Serdar Karakaya; Hasan Cagri Yildirim; Mustafa Erman

Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients

比较固定剂量与体重基础剂量纳武利尤单抗治疗非小细胞肺癌患者的疗效

Scientific Reports

IF3.9

2026-05-080

OAAI

Muhammet Cengiz; Oktay Bozkurt; Ayse Nuransoy Cengiz; Deniz Can Guven; Elif Sahin; Emel Mutlu Ozkan; Mustafa Ersoy; Ezgi Turkoğlu; Sedat Yildirim; Erdem Kolemen; Beyza Unlu; Hayati Arvas; Mehmet Mutlu Kidi; Sedat Biter; Latif Karahan; Mustafa Erman; Ismail Oguz Kara; Meltem Baykara; Pervin Can Sanci; Anıl Karakayali; Umut Kefeli; Devrim Cabuk; Saadettin Kilickap; Teoman Sakalar; Nargiz Majidova; Berrak Mermit Ercek; Muslih Urun; Gözde Agdas; Duygu Bayir; Cengiz Akosman; Erkam Kocaaslan; Havva Yesil Cinkir; Aslihan Ezgi Apaydin Rollas; Mevlude Inanc; Metin Ozkan

Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab

基线维生素D状态及接受纳武利尤单抗治疗的晚期非小细胞肺癌患者的临床结局

Scientific Reports

IF3.9

2026-04-140

OAAI

Gözde Ağdaş; Duygu Bayir; Elif Şahin; Muhammet Cengiz; Deniz Can Güven; Mehmet Salim Demir; Ertuğrul Bayram; Duygu Özaşkın; Meltem Baykara; Oktay Bozkurt; Mevlüde İnanç; Metin Özkan; Ayşe Nuransoy Cengiz; Mustafa Erman; Umut Kefeli; Emel Mutlu Özkan; Erkam Kocaaslan; Devrim Çabuk; Saadettin Kiliçkap; Pervin Can Sanci; Muslih Urun; Teoman Sakalar; Cengiz Akosman; Erdem Kolemen; Ezgi Turkoğlu; Anıl Karakayali; Mustafa Ersoy; Sedat Yildirim; Latif Karahan; Hayati Arvas; Mehmet Mutlu Kidi; Sedat Biter; Berrak Mermit Ercek; Nargiz Majidova; Havva Yesil Cinkir; Aslihan Ezgi Apaydin Rollas; İbrahim Karadağ

The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer

接受免疫疗法治疗的晚期肺癌患者中，早期肺部免疫预后指数变化的预后意义

Discover Oncology

IF2.9

2026-02-210

OAAI

Muhammet Cengiz; Oktay Bozkurt; Ayşe Nuransoy Cengiz; Mevlude Inanc; Metin Ozkan; Emel Mutlu Ozkan; Deniz Can Guven; Mustafa Erman; Latif Karahan; Elif Sahin; Anıl Karakayali; Pervin Can Sanci; Umut Kefeli; Devrim Cabuk; Erdem Kolemen; Mehmet Mutlu Kidi; Sedat Biter; Tolga Koseci; Muslih Urun; Berrak Mermit Ercek; Duygu Bayir; Gözde Agdas; Teoman Sakalar; Nargiz Majidova; Sedat Yildiz; Hacer Demir; Cengiz Akosman; Mustafa Ersoy; Saadettin Kilickap; Erkam Kocaaslan; Ezgi Turkoğlu; Sedat Yildirim; Hayati Arvas; Havva Yesil Cinkir; Aslihan Ezgi Apaydin Rollas

与健康相关的生活质量和免疫检查点抑制剂治疗长期存活者的心理社会结局：一项全国性多中心研究

Frontiers in Immunology

IF5.9

2025-12-100

Taha Koray Sahin; Fatih Atalah; Bahadir Koylu; Ahmet Oruc; Aydin Acarbay; Akgun Karakok; Sevgi Dogan; Cevat Ilteris Kikili; Görkem Turhan; Gamze Emin; Selahattin Celik; Ilknur Deliktas Onur; Tuba Ugur Tuzcu; Sedat Biter; Safa Can Efil; Fadime Sinem Ardic; Azer Gokmen; Halil Goksel Guzel; Kadri Turan; Ahmet Kürsad Disli; Salih Tunbekici; Erdem Goker; Mevlude Inanc; Ozlem Ozdemir; Banu Ozturk; Muslih Urun; Hatime Arzu Yasar; Mehmet Ali Nahit Sendur; Ismail Oguz Kara; Osman Sutcuoglu; Ozturk Ates; Tulay Eren; Atila Yildirim; Saadettin Kilickap; Omer Dizdar; Fatma Alev Turker; Mustafa Erman; Mehmet Artac; Fatih Selcukbiricik; Sercan Aksoy; Deniz Can Guven

Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program

avelumab维持治疗在真实世界扩展性准入计划中的转移性尿路上皮癌患者中的应用

Future Oncology

IF2.6

2025-10-160

PRE

Deniz Tural; Oğuzcan Özkan; Eda Eylemer Mocan; Caner Kapar; Sendag Yaslikaya; Ali Murat Tatlı; Goncagül Akdağ; Hacer Demir; Irem Bilgetekin; Fatih Selcukbiricik; Fatih Köse; Murat Sari; Gökmen Umut Erdem; Zehra Sucuoğlu İşleyen; Cagatay Arslan; Sinemis Celik; Türkkan Evrensel; Mustafa Erman; Seher Nazli Kazaz; Banu Ozturk; Halil Çelik; Miraç Özen; Pınar Erel; Pervin Can Şancı; Yaküp Ergün; Hakan Taban; Ömer Faruk Kuzu; Burcu Ulaş Kahya; Ahmet Melih Arslan; Abdullah Sakin; Murat Araz; Kerem Okutur; Fahri Akgül; Cem Mirili; Alper Sevinç; Fatih Atalah; Yakup Düzköprü; Burcu Gülbağcı; Serkan Yaşar; Nurten Kandemir; Hakan Kosku; Esra Aydın; Dilek Erdem; Murad Guliyev; Yaşar Çulha; Berksoy Şahin; Pınar Gürsoy; Yüksel Ürün

Pembrolizumab plus lenvatinib for previously untreated advanced non-clear cell renal cell carcinoma: 3-year follow-up of the phase 2 KEYNOTE-B61 study

帕博利珠单抗联合仑伐替尼用于初治的透明细胞肾细胞癌以外的晚期肾细胞癌：KEYNOTE-B61研究的3年随访结果

ONCOLOGIST

IF4.2

2025-10-012

OAAI

Evaluation of the Meet-URO Score in a Real-World Cohort of mRCC Patients Treated with First-Line TKIs

评估Meet-URO评分在真实世界接受一线TKIs治疗的mRCC患者队列中的应用

Journal of Clinical Medicine 2025, Vol. 14, Page 6385

IF0

2025-09-110

Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group

卡博替尼与舒尼替尼在晚期非透明细胞肾细胞癌中的真实世界比较：土耳其肿瘤学集团的多中心研究

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2025-09-010

PRE

Sahin, Gokhan; Tuzun, Esmanur Kaplan; Guzel, Halil G.; Guliyev, Murad; Disli, Ahmet K.; Yazici, Melike; Yildiz, Oguzhan; Gunes, Tugce K.; Alkan, Suleyman; Kahraman, Emir G.; Ozel, Gamze Serin; Icli, Mehmet C.; Sahin, Elif; Muglu, Harun; Acar, Caner; Tunbekici, Salih; Yuksel, Haydar C.; Yucel, Hakan; Kahya, Burcu Ulas; Kitapli, Sait; Buyuksimsek, Mahmut; Ipek, Suheda A.; Dama, Pinar E.; Usta, Ekin Akyildiz; Yilmaz, Mesut; Asik, Esra; Ozalp, Faruk R.; Savsar, Mehmet G.; Kocaaslan, Erkam; Sim, Saadet; Agaoglu, Ahmet B.; Camoz, Elif Sertesen; Demir, Teyfik; Uyar, Galip C.; Yildirim, Atila; Cinkir, Havva Y.; Salim, Derya Kivrak; Dogu, Gamze Gokoz; Alan, Ozkan; Bayram, Ertugrul; Karacin, Cengiz; Guc, Zeynep G.; Ekinci, Ferhat; Eryilmaz, Melek Karakurt; Semiz, Huseyin S.; Unal, Olcun U.; Goksu, Sema Sezgin; Ozturk, Banu; Inanc, Mevlude; Uygun, Kazim; Hacibekiroglu, Ilhan; Ercolak, Vehbi; Kara, Ismail O.; Yazici, Ozan; Bilici, Ahmet; Tanriverdi, Ozgur; Karaca, Burcak; Erman, Mustafa; Gokmen, Erhan; Goker, Erdem; Yildirim, Hasan Cagri

Model-Based Dose Selection and Pharmacokinetic Bridging of Subcutaneous from Intravenous Pembrolizumab Across Indications

基于模型的剂量选择及从静脉用帕博利珠单抗到皮下用帕博利珠单抗的药代动力学桥接研究（跨适应症）

European Journal of Cancer

IF7.1

2025-08-140

PREAI

Safety and efficacy of immune checkpoint inhibitors in patients with cancer and hepatitis B: multicentre experience in a low-middle-income country

免疫检查点抑制剂在癌症合并乙型肝炎患者中的安全性与有效性：来自一个中低收入国家的多中心经验

Expert Review of Anticancer Therapy

IF2.8

2025-07-060

PRE